New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies ...

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.

The Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization whose mission is to improve global health, recently announced a $1 million donation to the Patient Advocate ...

I-Mab Biopharma surged on promising givastomig results in gastric cancer. Click for my updated look at IMAB stock and why I ...

Pickering Interfaces has added two PXI and two PXIe battery simulators to its line of PXI test modules. The 41-754 (PXI) and ...

Originally published on BMS.com in recognition of Health Literacy Month, the following article highlights how Bristol Myers Squibb's Universal Patient Language (UPL) program is advancing clearer, more ...

Originally published on BMS.com in recognition of Health Literacy Month, the following article highlights how Bristol Myers ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

Recently, Bristol Myers Squibb (NYSE: BMY) and the National Community Pharmacists Association (NCPA) announced a new collaboration aimed at improving heart health in rural communities in the United ...

SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers ...

The deal will bolster BMS's cell therapy efforts by adding Orbital's lead program in autoimmune diseases and RNA platform to its portfolio.